ABIONYX Pharma SA (EPA: ABNX)

ABIONYX Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5.3	4.1	4.05	7.94	9.15	8.33
Cash & Short-Term Investments	5.3	4.1	4.05	7.94	9.15	8.33
Cash Growth	174.25%	1.43%	-49.01%	-13.32%	9.88%	-27.28%
Accounts Receivable	0.64	0.91	1.3	1.33	-	-
Other Receivables	1.23	1.58	1.76	3.29	0.84	1.76
Receivables	1.87	2.5	3.05	4.62	0.84	1.76
Inventory	0.2	0.22	0.15	0.18	-	-
Prepaid Expenses	0.17	0.07	0.33	0.28	0.04	0.02
Other Current Assets	-	-	-	-	-	0.01
Total Current Assets	7.55	6.89	7.57	13.01	10.03	10.13
Property, Plant & Equipment	2.18	2.22	2.56	3.07	0.12	0.09
Long-Term Investments	0.08	0.08	0.08	0.08	-	-
Goodwill	5.38	5.38	5.38	5.38	-	-
Other Intangible Assets	0.08	0.08	0.08	0.08	0.05	-
Other Long-Term Assets	0.14	0.14	0.12	0.19	0.1	0.03
Total Assets	15.46	14.83	15.82	21.83	10.29	10.25
Accounts Payable	1.15	1.44	1.85	2.71	2.41	1.26
Accrued Expenses	0.97	1.03	1.03	1.51	0.23	0.12
Short-Term Debt	-	0	0	0.17	-	-
Current Portion of Long-Term Debt	0.5	0.5	0.49	0.49	-	1.1
Current Portion of Leases	0.34	0.31	0.38	0.4	0.02	0.06
Current Unearned Revenue	0.32	0.59	0.38	0.43	0	-
Other Current Liabilities	0.03	0.06	0.96	1.04	0.93	0.93
Total Current Liabilities	3.31	3.93	5.09	6.75	3.6	3.47
Long-Term Debt	0.86	1.1	1.42	1.65	-	-
Long-Term Leases	1.47	1.47	1.73	2.25	-	0.02
Other Long-Term Liabilities	-	-	-	-	-	0.05
Total Liabilities	6.01	6.91	8.65	11.16	3.66	3.58
Common Stock	1.62	1.62	1.42	1.4	1.23	1.1
Additional Paid-In Capital	8.73	12.57	8.6	179.21	170.32	168.62
Retained Earnings	-2.09	-3.52	-4.21	-5.82	-1.89	1.85
Comprehensive Income & Other	1.18	-2.76	1.36	-164.11	-163.04	-164.9
Shareholders' Equity	9.45	7.92	7.17	10.68	6.63	6.67
Total Liabilities & Equity	15.46	14.83	15.82	21.83	10.29	10.25
Total Debt	3.17	3.39	4.01	4.96	0.02	1.18
Net Cash (Debt)	2.13	0.71	0.03	2.98	9.13	7.15
Net Cash Growth	-	2063.64%	-98.89%	-67.39%	27.73%	20.05%
Net Cash Per Share	0.07	0.02	0.00	0.12	0.39	0.34
Filing Date Shares Outstanding	32.46	32.21	28.1	27.7	24.4	21.63
Total Common Shares Outstanding	32.46	32.21	28.1	27.7	24.4	21.63
Working Capital	4.24	2.96	2.48	6.26	6.44	6.66
Book Value Per Share	0.29	0.25	0.26	0.39	0.27	0.31
Tangible Book Value	3.99	2.47	1.72	5.22	6.58	6.67
Tangible Book Value Per Share	0.12	0.08	0.06	0.19	0.27	0.31

Source: S&P Capital IQ. Standard template. Financial Sources.